AU2807689A - Method for the treatment of body tissues and the administration of drugs thereto - Google Patents

Method for the treatment of body tissues and the administration of drugs thereto

Info

Publication number
AU2807689A
AU2807689A AU28076/89A AU2807689A AU2807689A AU 2807689 A AU2807689 A AU 2807689A AU 28076/89 A AU28076/89 A AU 28076/89A AU 2807689 A AU2807689 A AU 2807689A AU 2807689 A AU2807689 A AU 2807689A
Authority
AU
Australia
Prior art keywords
drugs
administration
treatment
body tissues
tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28076/89A
Other languages
English (en)
Inventor
Edward S. Neiss
Charles G. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of AU2807689A publication Critical patent/AU2807689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU28076/89A 1986-09-19 1987-08-18 Method for the treatment of body tissues and the administration of drugs thereto Abandoned AU2807689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90983286A 1986-09-19 1986-09-19
US909832 1986-09-19

Publications (1)

Publication Number Publication Date
AU2807689A true AU2807689A (en) 1989-03-01

Family

ID=25427897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28076/89A Abandoned AU2807689A (en) 1986-09-19 1987-08-18 Method for the treatment of body tissues and the administration of drugs thereto

Country Status (4)

Country Link
EP (1) EP0324802A4 (ja)
JP (1) JPH01503146A (ja)
AU (1) AU2807689A (ja)
WO (1) WO1989000848A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614173B2 (en) * 1988-08-19 1991-08-22 Illinois Institute Of Technology Hemoglobin multiple emulsion
WO1995013818A1 (en) * 1993-11-15 1995-05-26 Baker Medical Research Institute A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5847009A (en) 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
DE4100059C2 (de) * 1991-01-03 1994-08-25 Adatomed Pharma & Med Behandlungsflüssigkeit zum Wiederanlegen (Entfalten) abgelöster Netzhaut an die Aderhaut des Auges
US5200430A (en) * 1991-03-21 1993-04-06 Escalon Ophthalmics, Inc. Debridement of bodily cavities using debridement fluids
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5641509A (en) * 1992-06-26 1997-06-24 Lancaster Group Ag Preparation for topical use
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
EP0692975A4 (en) * 1993-04-08 2000-11-29 Univ Queensland ADMINISTRATION OF A VASO ACTIVE AND A THERAPEUTIC ACTIVE
GB9308280D0 (en) * 1993-04-21 1993-06-02 Stead Gordon Thickening of fluorinated liquids
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE4405627A1 (de) * 1994-02-22 1995-08-24 Hoechst Ag Fluorkohlenwasserstoffe enthaltende Ölemulsionen
JP2012509870A (ja) * 2008-11-25 2012-04-26 オキシジェン・バイオセラピューティクス・インコーポレイティド ペルフルオロカーボンゲル製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2743842C2 (de) * 1976-10-01 1982-07-01 Matsushita Electric Industrial Co., Ltd., Kadoma, Osaka Trockenelektrolytkondensator und Verfahren zu dessen Herstellung
GB2070429B (en) * 1979-06-25 1984-05-02 Suntech Use of perfluorocarbon as burn treatment
BE881267A (fr) * 1980-01-18 1980-05-16 Stein Karl N Methode pour le traitement de brulures de la peau chez les mammiferes
EP0112658B1 (en) * 1982-11-26 1991-08-07 Children's Hospital Medical Center Extraocular device for treating the eye

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614173B2 (en) * 1988-08-19 1991-08-22 Illinois Institute Of Technology Hemoglobin multiple emulsion
WO1995013818A1 (en) * 1993-11-15 1995-05-26 Baker Medical Research Institute A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor

Also Published As

Publication number Publication date
WO1989000848A1 (en) 1989-02-09
JPH01503146A (ja) 1989-10-26
EP0324802A1 (en) 1989-07-26
EP0324802A4 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
AU4467589A (en) Treatment of skin diseases with artemisinin and derivatives
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU674894B2 (en) Treatment of conditions and disease
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
EG18268A (en) Medicament for the treatment of inflammation of the eye
AU591039B2 (en) Medical tool introduction cannula and method of manufacturing the same
AU7383687A (en) Pharmaceutical preparations containing formoterol or its salts, and a method of treating skin diseases
AU4438589A (en) A method of and apparatus for the medical-therapeutic treatment of the human body
AU5003990A (en) Method and device for the controlled local, non-invasive application of dc pulses to human tissues
AU6747887A (en) Treatment of skin disorders
AU1409488A (en) Coagulation treatment of fluids
AU2800689A (en) Differential delivery of therapeutic agents across the blood brain barrier
EP0378692A4 (en) Catheter for medical treatment
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
AU2347888A (en) Method and apparatus for P-synchronously stimulating the heart of a patient
AU4759390A (en) Method of medical treatment of alzheimer's disease
EP0270690A4 (en) MEDICINES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER AND KIDNEY DISEASES.
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
AU3861989A (en) Method for the treatment and the diagnosis of coronary heart disease
AU4058789A (en) Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof
EP0370115A4 (en) Catheter for diagnosis and therapy
AU6360486A (en) Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
AU8282187A (en) 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds